文献速递肝病

酒精性与非酒精性脂肪性肝病及肝脏相关死亡率:一项队列研究

Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

该队列研究纳入437,828名韩国成人,随访至多14年,比较非酒精性脂肪性肝病(NAFLD)与酒精性脂肪性肝病(AFLD)按纤维化严重程度分层的肝脏相关死亡率。结果显示,NAFLD和AFLD合并中高纤维化评分均与肝脏相关死亡率呈剂量依赖性升高相关,且在非肥胖个体中更明显。

要点

  • NAFLD患病率20.9%,AFLD患病率4.0%。
  • NAFLD高FIB-4评分肝脏相关死亡HR为84.66,AFLD为59.73。
  • 非肥胖者中关联比肥胖者更明显(交互P=0.004)。

核心结论

  • 在年轻和中年个体的大队列中,NAFLD和AFLD合并中高纤维化评分与肝脏相关死亡率风险升高呈剂量依赖性相关,尤其在非肥胖个体中。

研究设计与样本

  • 队列研究,纳入437,828名韩国成人,随访至多14年;超声诊断脂肪变,FIB-4评分判定纤维化严重程度,链接国家死亡记录确定生命状态和肝脏相关死亡。

主要发现

  • NAFLD患病率为20.9%,AFLD患病率为4.0%。
  • 随访3,145,541.1人年期间,识别出109例肝脏相关死亡,发病率为3.5/10人年。
  • NAFLD患者中,低、中、高FIB-4评分者肝脏相关死亡的多变量调整HR(95%CI)分别为0.43(0.19-0.94)、2.74(1.23-6.06)、84.66(39.05-183.54)。
  • AFLD患者中,低、中、高FIB-4评分者对应的HR(95%CI)分别为0.67(0.20-2.25)、5.44(2.19-13.49)、59.73(27.99-127.46)。
  • 非肥胖个体中关联比肥胖个体更明显(交互P=0.004)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared liver-related mortality by fibrosis severity between 2 types of fatty liver disease (FLD), nonalcoholic FLD (NAFLD) and alcoholic FLD (AFLD), in a large cohort of nonobese and obese individuals. METHODS: A cohort study was performed with 437,828 Korean adults who were followed up for up to 14 years. Steatosis was diagnosed based on ultrasonography; fibrosis severity was determined by the fibrosis 4 (FIB-4) score. Vital status and liver-related deaths were ascertained through linkage to national death records. RESULTS: The prevalence of NAFLD and AFLD was 20.9% and 4.0%, respectively. During 3,145,541.1 person-years of follow-up, 109 liver-related deaths were identified (incidence rate of 3.5 per 10 person-years). When changes in fatty liver status, FIB-4 scores, and confounders during follow-up were updated as time-varying covariates, compared with the reference (absence of both excessive alcohol use and FLD), the multivariable-adjusted hazard ratios with 95% confidence intervals for liver-related mortality among those with low, intermediate, and high FIB-4 scores were 0.43 (0.19-0.94), 2.74 (1.23-6.06), and 84.66 (39.05-183.54), respectively, among patients with NAFLD, whereas among patients with AFLD, the corresponding hazard ratios (95% confidence intervals) were 0.67 (0.20-2.25), 5.44 (2.19-13.49), and 59.73 (27.99-127.46), respectively. The associations were more evident in nonobese individuals than in obese individuals (P for interaction = 0.004). DISCUSSION: In this large cohort of young and middle-aged individuals, NAFLD and AFLD with intermediate to high fibrosis scores were associated with an increased risk of liver-related mortality in a dose-dependent manner, especially among nonobese individuals.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Chang Y, Cho YK, Cho J, et al. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study. Am J Gastroenterol. 2019. PMID: 30694866. doi:10.14309/ajg.0000000000000074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。